US FDA Grants Advanced Nod to Genfit and Ipsen's Liver Disease Drug

The U.S. Food and Drug Administration has granted advanced approval to the French drugmakers Ipsen and Genfit for their drug Iqirvo, which treats a chronic inflammatory liver disease called primary biliary cholangitis (PBC). PBC causes...

Hutchmed Commences Phase I trial of Menin Inhibitor HMPL-506 in Patients

Hutchmed (China) Limited has started a phase I clinical trial of its menin inhibitor HMPL-506 in patients with haematological malignancies in China. The very first patient received their initial dose on May 31, 2024. This is a stage I...

CordenPharma and Certest Ink Pact on Ionizable Lipids in LNP Formulation

CordenPharma, a worldwide CDMO pioneer in the production of drug substances (APIs) for complex modalities, LNPs containing xRNA/xDNA, and injectable medication items, and Certest, a Spanish organization focused on the improvement of new items with...

US FDA Nods Geron's Rytelo To Treat Patients with lower-risk MDS

Geron Enterprise, a business stage biopharmaceutical organization meaning to alter lives by changing the course of blood cancer, declared that the US Food and Medication Organization (FDA) has sanctioned Rytelo (imetelstat) for the treatment of...

MAIA Biotechnology Declares Clinical Progress For Novel Anticancer Agent

MAIA Biotechnology Inc, a clinical-stage biopharmaceutical organization creating designated immunotherapies for cancer, declared the highlights and key accomplishments year-to-date, including late clinical advancement for lead up-and-comer THIO...

Sermonix Pharma Bags Chinese Nod of IND application For lasofoxifene

Sermonix Pharmaceuticals LLC, a privately held biopharmaceutical firm developing cutting-edge therapeutics for the treatment of metastatic breast cancers (mBC), announced that China's National Medical Products Administration (NMPA) has approved...

Dept of Health Abu Dhabi and MSD Team up For Advance Clinical Research

During the BIO International Convention 2024 in San Diego, USA, the Department of Health – Abu Dhabi (DoH), the healthcare industry's regulator, and MSD, a top biopharmaceutical company, signed a Memorandum of Understanding (MoU). DoH and MSD...

Halozyme Secures European Patent For Enhanze Drug Delivery Platform

Halozyme Therapeutics, Inc, a biopharmaceutical firm, recently made the announcement that it had been granted European Patent No. 4269578. This patent covers the Enhanze rHuPH20 product that is made using Halozyme's Enhanze manufacturing methods...

Dept of Health Abu Dhabi and Opus Genetics Partner For Gene Therapy Research

Opus Genetics, a patient-first, clinical-stage gene therapy company developing treatments for inherited retinal diseases, and the Department of Health – Abu Dhabi (DoH), the Emirate's regulator of the healthcare sector, signed a Memorandum of...

AVS Bags IDE NOD From FDA For Pivotal Intravascular Lithotripsy Study

Amplitude Vascular Systems (AVS), a medical device company focused on the safe and effective treatment of severely calcified arterial disease, declared that it has received an investigational device exemption (IDE) from the United States Food and...

© 2025 India Pharma Outlook. All Rights Reserved.